Arcis Biotechnology provide nucleic acid sample preparation solutions. They have made the process of obtaining genetic material from biological samples less time consuming so it can be done in less than 3 minutes.
days to go:
Expired
investment:
£1,146,318
Living With is a health technology company offering a pocket-friendly and simple patient management application that allows medical professionals treat and track patients remotely. The app aims to revolutionise the way doctors and hospitals access digital tools to treat patients while collecting data for medical device and pharma companies. The company owns Squeezy (a popular paid medical app in the UK) and already has five products in 17 NHS Trusts. Living With also has a contract with one of the world’s greatest medical device companies. Living With will use the proceeds to give 5 data (drug/device) and 50 access customers (clinic/doctor), become HIPAA compliant for the US and to quicken sales and marketing.
days to go:
Expired
investment:
£200,000
Aerobit is a smart inhaler, a tool for tracking medication use that records each time inhalers are taken and comes in a variety of cool toy designs. Built in sensors can even tell if the inhaler has been shaken correctly.
days to go:
Expired
investment:
£116,960
Thymia aims to empower clinicians with cutting-edge Neuroscience and AI objectively identify and track mental illness using speech, facial movements and behaviour patterns, enabling personalised, efficient treatment and accurate remote monitoring. They have a large dataset, successful sales, and are raising funds for medical regulation, ADHD expansion, and patent filings.
days to go:
Expired
investment:
£1,126,464
A wind turbine's generator currently uses rare-earth magnets which cost £40 per kg, Greenspur have developed innovative generators which use ferrite magnets, an abundantly available material, that cost as little as £1 per kg. The company have made further advancements by removing the gearbox, which has resulted in lower maintenance costs and improved efficiency.
days to go:
Expired
investment:
£368,640
BiVictriX Therapeutics is a pharmaceutical company that are developing ADC's (Antibody Drug Conjugates) in the field of Oncology. They have invented a strategy that improves ADC selectivity towards cancer cells.
days to go:
Expired
investment:
£451,506
Riversimple is a car manufacturer and service provider that is spearheading ‘next-generation’ Hydrogen electric vehicles. It sells mobility as a service and retains ownership of its cars. Their pricing structure allows customers to pay a single monthly fee that covers the vehicle, fuel, maintenance, and insurance costs. It's proprietary offering, Rasa, is a two-seat local commuter vehicle that can achieve a 250mpg equivalent fuel figure with a 300-mile range from a 3-minute fill. The company has recently been awarded two new grants from The Office for Low Emission Vehicles (OLEV) for £1.25 million to support the build of its first low volume production run, and another from InnovateUK worth £0.5 million to support the deployment of cars in the Milford Haven Energy Kingdom project. The company has also been featured in several prominent publications such as The Guardian, CNBC, BBC Wales, Reuters and CNN to name a few. The company will use the investment to expand its engineering team and start volume production to reach product commercialisation by the end of 2022.
days to go:
Expired
investment:
£504,000
SMA Building and Maintenance Solution Ltd is an environmentally conscious company. based in Gloucester and was founded in 2019 by Suzanne Ackland. They serve a diverse clientele, including renowned brands like Ted Baker, Primark, Co-Op, and Barratt Developments. By combining their expertise, innovation, and unwavering commitment to quality, they create lasting and inspiring spaces. The company is presently in search of funds to support its expansion and refinancing efforts.
days to go:
Expired
investment:
£53,000
Regenerative Medical Group provides a remedy for Wound Healing and Erectile Dysfunction (ED) by using non-invasive technology. It partners with clinics to render the service such as reception, treatment rooms and nurses. In addition to the Erectile Dysfunction (ED) market, it has identified wound healing as a new market. Currently, it is working with an experienced NHS/NICE validation team to show its value as a treatment modality. RMG reached revenues of £400k, -56k EBITDA in the financial year 2017, and is operational in 5 clinics.
days to go:
Expired
investment:
£67,740
Speeding up access to mental health treatments by using electronic forms and universal communication tools. Thalamos has created a solution for multiple health entities such as the NHS, social services, charities, etc. The company aims to move these entities away from pen and paper, to an easy-to-use online platform, as manual entries are prone to information and data being misplaced, as well as prone to errors.
Thalamos's cloud platform will enable psychiatrists to reduce their clinical and information governance risk, whilst helping to continuously improve their patients' recovery process. The product will be subscription-based from £600 per year, which can be paid monthly and is in-line with other professional services.
days to go:
Expired
investment:
£171,548
